title: Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis.
abstract: Although simple steatosis was originally thought to be a pathologically inert histological change, fat accumulation in the liver may play a critical role not only in disease initiation, but also in the progression to nonalcoholic steatohepatitis and cirrhosis. Therefore, prevention of fat accumulation in the liver may be an effective therapy for multiple stages of nonalcoholic fatty liver disease (NAFLD). Promising beneficial effects of betaine supplementation on human NAFLD have been reported in some pilot clinical studies; however, data related to betaine therapy in NAFLD are limited. In this study, we examined the effects of betaine on fat accumulation in the liver induced by high-sucrose diet and evaluated mechanisms by which betaine could attenuate or prevent hepatic steatosis in this model. Male C57BL/6 mice weighing 20 +/- 0.5 g (means +/- SE) were divided into four groups (8 mice per group) and started on one of four treatments: standard diet (SD), SD+betaine, high-sucrose diet (HS), and HS + betaine. Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous). Long-term feeding of high-sucrose diet to mice caused significant hepatic steatosis accompanied by markedly increased lipogenic activity. Betaine significantly attenuated hepatic steatosis in this animal model, and this change was associated with increased activation of hepatic AMP-activated protein kinase (AMPK) and attenuated lipogenic capability (enzyme activities and gene expression) in the liver. Our findings are the first to suggest that betaine might serve as a therapeutic tool to attenuate hepatic steatosis by targeting the hepatic AMPK system.
authors: Dept. of Medicine, Univ. of Louisville Medical Center, Louisville, KY 40292, USA. z0song02@louisville.edu
authors: Zhenyuan
authors: Z
authors: Song
authors: Ion
authors: I
authors: Deaciuc
authors: Zhanxiang
authors: Z
authors: Zhou
authors: Ming
authors: M
authors: Song
authors: Theresa
authors: T
authors: Chen
authors: Daniell
authors: D
authors: Hill
authors: Craig J
authors: CJ
authors: McClain
mesh_terms: D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase / Q000378:metabolism; D000818:Animals; D001622:Betaine / Q000627:therapeutic use*; D002460:Cell Line; D004040:Dietary Carbohydrates / Q000008:administration & dosage*; D004195:Disease Models, Animal; D005234:Fatty Liver / Q000188:drug therapy*; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009097:Multienzyme Complexes / Q000502:physiology*; D017346:Protein Serine-Threonine Kinases / Q000502:physiology*; D013395:Sucrose / Q000008:administration & dosage*
chemical_list: D004040:Dietary Carbohydrates; D009097:Multienzyme Complexes; D001622:Betaine; D013395:Sucrose; D017346:Protein Serine-Threonine Kinases; D055372:AMP-Activated Protein Kinases; D000103:Acetyl-CoA Carboxylase
references: Diabetes Obes Metab. 2006 May;8(3):264-80
references: 16634986
references: Biochimie. 2005 Jan;87(1):87-91
references: 15733742
references: J Clin Invest. 2006 Jul;116(7):1776-83
references: 16823475
references: Biochim Biophys Acta. 2000 Jun 26;1486(1):1-17
references: 10856709
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10072-7
references: 12122204
references: Hepatology. 1995 Dec;22(6):1714-9
references: 7489979
references: Semin Liver Dis. 2004 Feb;24(1):99-106
references: 15085490
references: Alcohol Clin Exp Res. 1997 Sep;21(6):1100-2
references: 9309323
references: Hepatology. 2002 Oct;36(4 Pt 1):829-39
references: 12297830
references: Semin Liver Dis. 2001;21(1):89-104
references: 11296700
references: Mol Cell Biochem. 2003 Nov;253(1-2):65-70
references: 14619957
references: Biochem Soc Trans. 2003 Feb;31(Pt 1):220-3
references: 12546689
references: J Clin Invest. 2003 Jul;112(1):91-100
references: 12840063
references: Am J Clin Nutr. 2004 Sep;80(3):539-49
references: 15321791
references: J Hepatol. 2007 Feb;46(2):314-21
references: 17156888
references: Mayo Clin Proc. 1980 Jul;55(7):434-8
references: 7382552
references: Hepatology. 2004 Oct;40(4):989-97
references: 15382170
references: J Biol Chem. 2004 Nov 12;279(46):47898-905
references: 15371448
references: Diabetes. 2005 May;54(5):1331-9
references: 15855317
references: J Clin Invest. 2001 Oct;108(8):1167-74
references: 11602624
references: N Engl J Med. 2000 Nov 16;343(20):1467-76
references: 11078773
references: Am J Gastroenterol. 2001 Sep;96(9):2711-7
references: 11569700
references: Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2557-62
references: 9122234
references: J Hepatol. 1998 Sep;29(3):495-501
references: 9765002
references: Clin Liver Dis. 2004 Aug;8(3):575-94, ix
references: 15331065
references: J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S17-29
references: 16540762
references: Gastroenterology. 2003 May;124(5):1488-99
references: 12730887
references: Can J Biochem Physiol. 1959 Aug;37(8):911-7
references: 13671378
references: J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S61-6
references: 16540770
references: Biochem Pharmacol. 2005 Dec 5;70(12):1883-90
references: 16253211
references: Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E175-81
references: 16464908
references: J Biol Chem. 2002 Sep 6;277(36):32571-7
references: 12065578
references: J Hepatol. 2003 Dec;39(6):978-83
references: 14642615
references: Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G1-6
references: 15194557
references: Arterioscler Thromb Vasc Biol. 2006 May;26(5):1043-50
references: 16497994
references: Arzneimittelforschung. 2000 Aug;50(8):722-7
references: 10994156
references: J Biol Chem. 2002 Feb 8;277(6):3829-35
references: 11724780
references: J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S186-90
references: 12000605
references: Am J Physiol Gastrointest Liver Physiol. 2000 Jul;279(1):G178-85
references: 10898761